Pakistan will soon receive Russia’s Sputnik V COVID-19 vaccine for commercial sale, a company official said on Sunday, making Pakistan one of the first countries to market shots privately as it scrambles to secure supplies.
The Sputnik V vaccine has been shown to be 91.6 % effective. Already authorized for use in Pakistan.
Despite concerns over fairness and higher prices, Islamabad agreed this week to allow the commercial import and sale of vaccines without price caps, in contrast to most countries, which are importing and administering vaccines through government channels.
“We are told the first shipment is expected within the next week,” Chughtai Lab director Omar Chughtai told to international news agency, adding it would be receiving several thousand doses.
Sputnik V is one of four vaccines approved for emergency use in Pakistan, in addition to those by China’s Sinopharm and CanSinoBio, and the AstraZeneca-Oxford University shot.
Chughtai Lab aims to import the others as well, but Sputnik V was the first to become available, Chughtai said.